TherOx's Unattributed VC - IV Round

TherOx raised a round of funding on May 10, 2018. Investors include Cutlass Capital.

TherOx is a medical device company dedicated to elevating the standard of care for treatment of heart attack patients. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage dama…

Articles about TherOx's Unattributed VC - IV Round: